Kia ora Mark
  
Thank you for your requests for official information. Manatū Hauora (the
Ministry of Health) has consolidated the below two requests under section
18(A)(1) of the Act. The reference number for your consolidated request
is: H2023032160
  
As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  
  
If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account. 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.
 
 
Ngā mihi
 
OIA Services Team
Manatū Hauora | Ministry of Health
M[4]inistry of Health information releases 
U[5]nite against COVID-19
 

-----Original Message-----
From: Mark Shelly <[FOI #24338 email]>
Sent: Wednesday, 4 October 2023 11:18 am
To: OIA Requests <[email address]>
Subject: Official Information request - Hospital discharges with a
principal diagnosis of myocarditis

Dear Ministry of Health,
Report:
[6]https://www.health.govt.nz/news-media/me...
Claim:
There are many possible causes of myocarditis, the most common being viral
infection; an average of 95 people (SAFE study) are discharged from
hospital with a principal diagnosis of myocarditis in New Zealand every
year.
Please provide a copy of the report referred to above.
Please provide updated statistics (ie number of people discharged from
hospital with a principal diagnosis of myocarditis in NZ every year
subsequent to dates used in this study.
Please stratify by age and sex if possible.
Yours faithfully,
Mark Shelly

-----Original Message-----
From: Mark Shelly <[email address]>
Sent: Wednesday, 4 October 2023 11:01 am
To: OIA Requests <[email address]>
Subject: Official Information request - Myocarditis by COVID-19 Infection
v by Vaccine - NZ Males 16 to 29

Dear Ministry of Health,
Regarding covid-19 vaccine independent safety monitoring board media
release of 20 Dec 2021.
[7]https://www.health.govt.nz/news-media/me...
Please provide evidence supporting the claim that:
COVID-19 infection increases the risk of myocarditis substantially more
than vaccination with the Pfizer vaccine.
The statement refers to an Israeli study. Please advise if it is this
study:
[8]https://aus01.safelinks.protection.outlo...
If it is not this study, please advise what study the statement refers to.
The above study found that for males aged between 16 and 29 the incidence
of myocarditis following receipt of a Comirnaty injection exceeded 1 in
10,000.
"The highest incidence (10.69 cases per 100,000 persons; 95% CI, 6.93 to
14.46) was observed among male patients between the ages of 16 and 29
years."
The statement claims that the risk of myocarditis from COVID-19 infection
is much greater than from COVID-19 vaccination. Please advise what rate of
myocarditis the ministry attributes as resulting from a COVID-19 infection
in this cohort (males 16 to 29) and what source it uses to substantiate
this claim.
Please provide evidence that vaccination (1) protects individuals from
contracting COVID-19 and (2) reduces the rate of the occurrence
myocarditis if infected (include the rate of reduction of infection that
vaccination results in and how this has been established). It would be
particularly helpful if this evidence was stratified by age and sex (eg,
in males aged 16 - 29 it has been shown that for every 1,000 vaccine doses
administered 999 individuals have been protected against infection).
Yours faithfully,
Mark Shelly

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...
5. https://covid19.govt.nz/
6. https://www.health.govt.nz/news-media/me...
7. https://www.health.govt.nz/news-media/me...
8. https://www.nejm.org/doi/full/10.1056/NE...

hide quoted sections